Logo Image
News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gallbladder Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Mesothelioma
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
    • Small Lymphocytic Lymphoma (SLL)
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Advanced Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement

Bern Pollock

Advertisement

Articles by Bern Pollock

Bern Pollock

Why Ostomy Supplies Are Not One Size Fits All for Cancer Survivors

ByBern Pollock
October 5th 2026

Bern Pollock uses close to 10 products from different manufacturers to manage his urostomy after bladder cancer. He explains why Medicare bidding concerns him.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on CURE

    1

    5 Years of Breast Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients

    2

    Phase 3 Trial Shows Adding Imdelltra to First-Line Treatment Helps Patients With SCLC Live Longer

    3

    Six Years Later, Most Myeloma Patients on a Darzalex Regimen Are Still Progression-Free

    4

    Radiation Oncologist Answers Top Questions About Radiation Therapy

    5

    10 Cancer Treatment Approvals From September 2026 and What They Mean for You

    • About Us
    • Advertise / Support
    • Editorial Board
    • Contact Us
    • CancerNetwork.com
    • TargetedOnc.com
    • OncLive.com
    • OncNursingNews.com
    • Terms & Conditions
    • Privacy
    • Do Not Sell My Information
    • Washington My Health My Data
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.